CME Group Inc.(CME)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CME | 101.42 B | 23.90x | 0.80% | 63.44% | $11.80 | 15.80% | 0.15 | 1.82% | $319.82 | $218.31 |
SPGI | 132.83 B | 27.87x | 10.40% | 30.54% | $16.17 | 14.26% | 0.43 | 88.00% | $444.82 | $422.94 |
ICE | 92.40 B | 23.21x | 4.80% | 38.25% | $7.09 | 14.09% | 0.69 | 1.28% | $174.83 | $121.79 |
MCO | 87.34 B | 32.66x | 15.10% | 34.25% | $15.44 | 76.93% | 2.41 | 80.00% | $543.25 | $399.61 |
Peer Valuation & Performance Analysis
Peer group analysis for CME Group Inc. (CME) compared to its primary competitors (including SPGI, ICE, MCO) reveals distinct metrics. CME trades at a valuation discount relative to its competitors, with a P/E ratio of 23.9x versus the peer average of 27.9x (representing a 14% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, CME's revenue growth of 0.8% lags behind the peer average of 10.1%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 63.4% compared to the peer average of 34.3%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CME ranks #2 in P/E ratio, #4 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $280.72 | $283.30 | $279.43 | $282.05 | 1,739,900 | +0.47% |
| 2026-09-02 | $285.61 | $286.14 | $275.63 | $277.77 | 2,466,200 | -2.75% |
| 2026-09-01 | $286.39 | $289.90 | $282.94 | $286.45 | 1,664,500 | +0.02% |
| 2026-08-31 | $284.15 | $287.44 | $282.87 | $285.50 | 3,293,700 | +0.48% |
| 2026-08-28 | $281.20 | $286.30 | $279.86 | $285.80 | 2,981,900 | +1.64% |
| 2026-08-27 | $280.09 | $282.71 | $279.46 | $280.94 | 2,058,100 | +0.30% |
| 2026-08-26 | $278.41 | $282.17 | $277.76 | $280.98 | 1,722,500 | +0.92% |
| 2026-08-25 | $277.00 | $279.36 | $273.22 | $277.32 | 1,403,400 | +0.12% |
| 2026-08-24 | $276.17 | $279.78 | $274.15 | $279.17 | 1,318,000 | +1.09% |
| 2026-08-21 | $272.58 | $275.50 | $271.64 | $274.98 | 1,815,100 | +0.88% |
| 2026-08-20 | $266.94 | $273.18 | $266.42 | $270.87 | 1,567,400 | +1.47% |
| 2026-08-19 | $270.25 | $272.30 | $262.20 | $266.94 | 2,561,400 | -1.22% |
| 2026-08-18 | $271.36 | $274.00 | $269.06 | $271.54 | 1,488,900 | +0.07% |
| 2026-08-17 | $269.32 | $271.83 | $267.67 | $267.88 | 2,150,700 | -0.53% |
| 2026-08-14 | $266.88 | $271.09 | $265.56 | $269.80 | 1,717,100 | +1.09% |
Explore More Analysis for CME
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.